These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 1964232

  • 1. Complex assessment of tumor cell proliferation in various forms of lung cancer.
    Kazantseva IA, Machmudova GK.
    Acta Histochem Suppl; 1990; 39():155-62. PubMed ID: 1964232
    [Abstract] [Full Text] [Related]

  • 2. [Complex evaluation of the proliferative activity of tumor cells in different histological variants of lung cancer].
    Kazantseva IA, Makhmudova GK, Kotel'nikov VM.
    Eksp Onkol; 1987; 9(2):42-6. PubMed ID: 3034549
    [Abstract] [Full Text] [Related]

  • 3. [Proliferation and mitotic performance of lung cancer].
    Kazantseva IA, Makhmudova GK.
    Vopr Onkol; 1984; 30(7):60-3. PubMed ID: 6087559
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology.
    Ołszewski W, Darzynkiewicz Z, Claps ML, Melamed MR.
    Anal Quant Cytol; 1982 Jun; 4(2):90-8. PubMed ID: 6287892
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H, Mikami T, Iwabuchi K, Yokoyama M, Hattori M, Ohno E, Kuramoto H, Jiang SX, Okayasu I.
    Cancer; 2003 Aug 25; 99(4):247-54. PubMed ID: 12925987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H, Kappatou G, Yiagnisis M, Field JK, Spandidos DA.
    Anticancer Res; 1990 Aug 25; 10(3):597-603. PubMed ID: 2164347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
    Teodori L, Tirindelli-Danesi D, Mauro F, De Vita R, Uccelli R, Botti C, Modini C, Nervi C, Stipa S.
    Cytometry; 1983 Sep 25; 4(2):174-83. PubMed ID: 6313307
    [Abstract] [Full Text] [Related]

  • 10. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 25; 30(10):771-5. PubMed ID: 18218209
    [Abstract] [Full Text] [Related]

  • 11. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
    Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K.
    Cytometry; 1985 Jul 25; 6(4):348-56. PubMed ID: 2990835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K, Hayashi Y, Nagao S, Watanabe Y.
    Gan To Kagaku Ryoho; 1995 Jun 25; 22 Suppl 2():164-7. PubMed ID: 7611782
    [Abstract] [Full Text] [Related]

  • 15. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
    Shibamoto Y, Ike O, Mizuno H, Fukuse T, Hitomi S, Takahashi M.
    Clin Cancer Res; 1998 Mar 25; 4(3):677-82. PubMed ID: 9533537
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L, Nikliński J, Chyczewska E, Laudański J, Furman M.
    Rocz Akad Med Bialymst; 1997 Mar 25; 42 Suppl 1():162-72. PubMed ID: 9337534
    [Abstract] [Full Text] [Related]

  • 17. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE.
    Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021
    [Abstract] [Full Text] [Related]

  • 18. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J, Peltri G, Bitterlich N, Neu K, Velcovsky HG, Morr H, Katz N, Eigenbrodt E.
    Anticancer Res; 2003 Feb 15; 23(2A):899-906. PubMed ID: 12820320
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.
    Moran RE, Melamed MR.
    Anal Quant Cytol; 1984 Jun 15; 6(2):99-104. PubMed ID: 6205621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.